Demonstrates antioxidant and hypoglycemic properties of a novel polysaccharide from Lentinula sp., suggesting its potential for diabetes management.
Lentinula sp. as an edible fungus in China, the bioactivity of its polysaccharide has not been exploited. In this study, the polysaccharides from Lentinula sp. were extracted and purified, the structural, antioxidant and hypoglycaemic properties of a novel Lentinula sp. polysaccharide (HMP-1) were characterised. Structural analysis identified HMP-1 as a β-glycosidic-linked heteropolysaccharide (89.15 kDa) made of glucose, galactose, and glucuronic acid, with a porous flake-like structure. HMP-1 showed strong antioxidant activity in DPPH (46.78%), ABTS (90.57%), and ORAC (393.69 μmol TE/mg) assays. It also significantly inhibited α-glucosidase and α-amylase by 76.65 and 81.15%, respectively. In insulin-resistant HepG2 cells, HMP-1 decreased ROS levels by 35.7%, restored SOD and CAT activities, and increased glucose consumption by 58.3. These findings highlight HMP-1 as a promising natural hypoglycaemic agent with dual antioxidant and enzyme inhibitory effects, providing novel insights into structure-activity relationships of natural polysaccharides for diabetes management.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: